Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Welcia Holdings Co's average EBITDA Per Share Growth Rate was 66.10% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -4.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 1.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 9.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Welcia Holdings Co was 22.20% per year. The lowest was -4.60% per year. And the median was 12.50% per year.
Welcia Holdings Co (OTCPK:WLCGF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Welcia Holdings Co 3-Year EBITDA Growth Rate Related Terms
Welcia Holdings Co 3-Year EBITDA Growth Rate Competitor Comparison
For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcia Holdings Co 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Welcia Holdings Co's 3-Year EBITDA Growth Rate falls into.
Welcia Holdings Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -4.60% mean?
Welcia Holdings Co (WLCGF) has a 3-Year EBITDA Growth Rate of -4.60% as of Aug. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Welcia Holdings Co and its competitors.
Is Welcia Holdings Co's 3-Year EBITDA Growth Rate too high?
Welcia Holdings Co's current 3-Year EBITDA Growth Rate is -4.60%. Overall, Welcia Holdings Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Welcia Holdings Co's 3-Year EBITDA Growth Rate compare to competitors?
Welcia Holdings Co's 3-Year EBITDA Growth Rate of -4.60% can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Welcia Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcia Holdings Co's current 3-Year EBITDA Growth Rate is -4.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcia Holdings Co stock overvalued right now?
Welcia Holdings Co (WLCGF) has a current 3-Year EBITDA Growth Rate of -4.60%. The stock's GF Value™ is $14.20, compared to a current price of $16.41 — trading 15.6% above its estimated fair value. The current 3-Year EBITDA Growth Rate is -4.60%. Welcia Holdings Co's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Welcia Holdings Co (WLCGF), the current 3-Year EBITDA Growth Rate is -4.60% as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Welcia Holdings Co (WLCGF) Overvalued in 2026?
Based on GuruFocus' analysis, Welcia Holdings Co stock appears to be overvalued.
The current stock price of $16.41 is trading 15.6% above its estimated GF Value™ of $14.20.
Key valuation signals for WLCGF:
3-Year EBITDA Growth Rate: -4.60%
GF Value™: $14.20 vs. price of $16.41 (15.6% above fair value)
No single metric tells the full story. See the WLCGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.
18GF Score
Get the complete analysis for WLCGF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WLCGF has been successfully added to your 
